Key Human Genetics Market Players:
- Myriad Genetics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Synlab Group
- Eurofins Megalab S.A
- Biomarker Technology
- Echevarne Laboratory
- Elabscience Biotechnology Inc
- NIMGenetics
- Sistemas Genómicos
- FullGenomics
- GENinCode
- Atrys Health
The human genetics market is fiercely competitive and consolidated in nature, with key major players including Myriad Genetics, LabCorp, GE Healthcare, QIAGEN, Agilent Technologies, Thermo Fisher Scientific, Illumina, Promega, Bio-Rad Laboratories, Bode Technology, Orchid Cellmark, and LGC Forensics. These companies focus on extending genetic testing portfolios through continuous technological development, partnerships, and acquisitions. The competitive landscape of the industry depicts a strong focus on precision medicine, wherein leading market players invest intensively in R&D to introduce new genetic tests and personalized healthcare solutions.
In September 2023, Myriad Genetics and Illumina announced two significant deal milestones for the advancement of genomic profiling and homologous recombination deficiency testing. The deal represents the strategic alliance trend among key players to advance specialized genetic diagnostics development. This partnership further highlights the importance of pooling resources and expertise to meet the rising demand for precision medicine, intensifying competition in the global human genetics market.
Here are some leading players in the human genetics market:
